Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

9342-8530 Quebec Inc > Mr. Todd Axelrod Proposition
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by YOURBOSS8on Apr 15, 2013 7:27pm
188 Views
Post# 21257002

RE: RE: RE: RE: Mr. Todd Axelrod Proposition

RE: RE: RE: RE: Mr. Todd Axelrod Proposition

Interesting the Fadet didn't mention that he owns 2,000,000 shares in the press release.  So the rest of his team own what?  ...  nice comparison.

I'm tired of Fadet and his team.  They keep us in the dark and do not correspond with shareholders (at least I don't have luck getting replies).

Time for change.  I'm voting against current leaders.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities